| Nuclear signalling by tumour-associated antigen EpCAM D Maetzel, S Denzel, B Mack, M Canis, P Went, M Benk, C Kieu, P Papior, ... Nature cell biology 11 (2), 162-171, 2009 | 796 | 2009 |
| The emerging role of EpCAM in cancer and stem cell signaling M Munz, PA Baeuerle, O Gires Cancer research 69 (14), 5627-5629, 2009 | 626 | 2009 |
| Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule O Gires, U Zimber‐Strobl, R Gonnella, M Ueffing, G Marschall, R Zeidler, ... The EMBO journal, 1997 | 614 | 1997 |
| EpCAM (CD326) finding its role in cancer PA Baeuerle, O Gires British journal of cancer 96 (3), 417-423, 2007 | 528 | 2007 |
| The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation M Münz, C Kieu, B Mack, B Schmitt, R Zeidler, O Gires Oncogene 23 (34), 5748-5758, 2004 | 479 | 2004 |
| Latent membrane protein 1 of Epstein–Barr virus interacts with JAK3 and activates STAT proteins O Gires, F Kohlhuber, E Kilger, M Baumann, A Kieser, C Kaiser, R Zeidler, ... The EMBO journal, 1999 | 478 | 1999 |
| Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer E Hartmann, B Wollenberg, S Rothenfusser, M Wagner, D Wellisch, ... Cancer research 63 (19), 6478-6487, 2003 | 425 | 2003 |
| Epstein–Barr virus latent membrane protein‐1 triggers AP‐1 activity via the c‐Jun N‐terminal kinase cascade A Kieser, E Kilger, O Gires, M Ueffing, W Kolch, W Hammerschmidt The EMBO journal, 1997 | 414 | 1997 |
| Characterization of rare, dormant, and therapy-resistant cells in acute lymphoblastic leukemia S Ebinger, EZ Özdemir, C Ziegenhain, S Tiedt, CC Alves, M Grunert, ... Cancer cell 30 (6), 849-862, 2016 | 268 | 2016 |
| EpCAM and its potential role in tumor-initiating cells S Imrich, M Hachmeister, O Gires Cell adhesion & migration 6 (1), 30-38, 2012 | 224 | 2012 |
| CD44s and CD44v6 expression in head and neck epithelia B Mack, O Gires PloS one 3 (10), e3360, 2008 | 214 | 2008 |
| Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years? O Gires, M Pan, H Schinke, M Canis, PA Baeuerle Cancer and Metastasis Reviews 39 (3), 969-987, 2020 | 192 | 2020 |
| Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis X Liu, J Li, BL Cadilha, A Markota, C Voigt, Z Huang, PP Lin, DD Wang, ... Science advances 5 (6), eaav4275, 2019 | 178 | 2019 |
| Latent membrane protein 1 of Epstein–Barr virus coordinately regulates proliferation with control of apoptosis U Dirmeier, R Hoffmann, E Kilger, U Schultheiss, C Briseño, O Gires, ... Oncogene 24 (10), 1711-1717, 2005 | 178 | 2005 |
| Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer P Ruf, O Gires, M Jäger, K Fellinger, J Atz, H Lindhofer British journal of cancer 97 (3), 315-321, 2007 | 165 | 2007 |
| On the abundance of EpCAM on cancer stem cells O Gires, CA Klein, PA Baeuerle Nature Reviews Cancer 9 (2), 143-143, 2009 | 164 | 2009 |
| EpCAM is involved in maintenance of the murine embryonic stem cell phenotype B González, S Denzel, B Mack, M Conrad, O Gires Stem cells 27 (8), 1782-1791, 2009 | 139 | 2009 |
| TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling R Zhu, O Gires, L Zhu, J Liu, J Li, H Yang, G Ju, J Huang, W Ge, Y Chen, ... Nature communications 10 (1), 2863, 2019 | 136 | 2019 |
| EpCAM and the biology of hepatic stem/progenitor cells L Dollé, ND Theise, E Schmelzer, L Boulter, O Gires, LA van Grunsven American Journal of Physiology-Gastrointestinal and Liver Physiology 308 (4 …, 2015 | 136 | 2015 |
| EpCAM regulates cell cycle progression via control of cyclin D1 expression A Chaves-Perez, B Mack, D Maetzel, H Kremling, C Eggert, U Harreus, ... Oncogene 32 (5), 641-650, 2013 | 127 | 2013 |
